• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性补体调节因子 H 和 FHL-1 的自我与非我识别。

Self versus Nonself Discrimination by the Soluble Complement Regulators Factor H and FHL-1.

机构信息

Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, 89081 Ulm, Germany.

Institute of Clinical and Experimental Trauma-Immunology, University Hospital, 89081 Ulm, Germany.

出版信息

J Immunol. 2019 Apr 1;202(7):2082-2094. doi: 10.4049/jimmunol.1801545. Epub 2019 Feb 11.

DOI:10.4049/jimmunol.1801545
PMID:30745459
Abstract

The plasma proteins Factor H (FH) and its alternate splice variant FH-like protein 1 (FHL-1) are the major regulators of the complement alternative pathway. The indiscriminate nature of alternative pathway activation necessitates the regulators to be host selective, but the underlying principles of selectivity remained largely elusive. By analyzing human FH and FHL-1 for protection of different host and foreign cells (rabbit and yeast), we uncovered a 2-fold discriminatory mechanism of FH in favor of self: relative to FHL-1, FH exhibits a regulatory benefit on self but importantly, also, a regulatory penalty on nonself surfaces, yielding a selectivity factor of ∼2.4 for sialylated host surfaces. We further show that FHL-1 possesses higher regulatory activity than known but is relatively unselective. The reason for this unexpected high activity of FHL-1 is the observation that the complement regulatory site in FH exceeds the established first four domains. Affinity for C3b, cofactor and decay-accelerating activities, and serum assays demonstrate that the regulatory site extends domains 1-4 and includes domains 5-7. But unlike FH, FHL-1 exhibits a fast plasma clearance in mice, occurs sparsely in human plasma (at one fortieth of the FH concentration), and resists deregulation by FH-related proteins. These physiological differences and its late phylogenetic occurrence argue that FHL-1 is crucial for local rather than systemic compartments. In conclusion, we demonstrate a 2-fold discriminatory power of FH to promote selectivity for self over foreign and show that FHL-1 is more active than known but specialized for regulation on local tissues.

摘要

血浆蛋白因子 H(FH)及其交替剪接变体 FH 样蛋白 1(FHL-1)是补体替代途径的主要调节剂。替代途径激活的无差别性质需要调节剂具有宿主选择性,但选择性的基本原理在很大程度上仍然难以捉摸。通过分析人类 FH 和 FHL-1 对不同宿主和外来细胞(兔和酵母)的保护作用,我们发现了 FH 有利于自身的 2 倍区分机制:与 FHL-1 相比,FH 对自身表现出调节优势,但重要的是,对非自身表面也表现出调节劣势,产生了对唾液酸化宿主表面的选择性因子约为 2.4。我们进一步表明,FHL-1 具有比已知的更高的调节活性,但相对不具有选择性。FHL-1 具有这种出乎意料的高活性的原因是观察到 FH 中的补体调节位点超过了公认的前四个结构域。对 C3b 的亲和力、辅助因子和衰变加速活性以及血清测定表明,调节位点延伸到结构域 1-4,并包括结构域 5-7。但与 FH 不同,FHL-1 在小鼠中表现出快速的血浆清除,在人类血浆中(仅为 FH 浓度的四十分之一)出现稀疏,并抵抗 FH 相关蛋白的去调节。这些生理差异及其在系统发生上的后期出现表明,FHL-1 对于局部而非全身隔室至关重要。总之,我们证明了 FH 具有 2 倍的区分能力,以促进自身对外国的选择性,并表明 FHL-1 比已知的更活跃,但专门用于局部组织的调节。

相似文献

1
Self versus Nonself Discrimination by the Soluble Complement Regulators Factor H and FHL-1.可溶性补体调节因子 H 和 FHL-1 的自我与非我识别。
J Immunol. 2019 Apr 1;202(7):2082-2094. doi: 10.4049/jimmunol.1801545. Epub 2019 Feb 11.
2
Comparative Analysis of Novel Complement-Targeted Inhibitors, MiniFH, and the Natural Regulators Factor H and Factor H-like Protein 1 Reveal Functional Determinants of Complement Regulation.新型补体靶向抑制剂、微型补体调节蛋白FH以及天然调节因子H和类补体调节蛋白1的比较分析揭示了补体调节的功能决定因素。
J Immunol. 2016 Jan 15;196(2):866-76. doi: 10.4049/jimmunol.1501919. Epub 2015 Dec 7.
3
Tuning the Functionality by Splicing: Factor H and Its Alternative Splice Variant FHL-1 Share a Gene but Not All Functions.通过拼接调节功能:因子 H 与其替代拼接变体 FHL-1 共享基因但并非所有功能。
Front Immunol. 2020 Oct 15;11:596415. doi: 10.3389/fimmu.2020.596415. eCollection 2020.
4
Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.志贺毒素 2 与补体因子 H 蛋白家族调节物的相互作用。
Mol Immunol. 2014 Mar;58(1):77-84. doi: 10.1016/j.molimm.2013.11.009. Epub 2013 Dec 5.
5
Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding.A组链球菌的吞噬抗性独立于补体因子H和H因子样蛋白1结合。
Mol Microbiol. 2001 Aug;41(4):817-26. doi: 10.1046/j.1365-2958.2001.02496.x.
6
Role of Gonococcal Neisserial Surface Protein A (NspA) in Serum Resistance and Comparison of Its Factor H Binding Properties with Those of Its Meningococcal Counterpart.淋球菌表面蛋白 A(NspA)在血清抗性中的作用及其与脑膜炎奈瑟菌对应物的因子 H 结合特性比较。
Infect Immun. 2019 Jan 24;87(2). doi: 10.1128/IAI.00658-18. Print 2019 Feb.
7
Haemophilus influenzae interacts with the human complement inhibitor factor H.流感嗜血杆菌与人类补体抑制因子H相互作用。
J Immunol. 2008 Jul 1;181(1):537-45. doi: 10.4049/jimmunol.181.1.537.
8
Hijacking Factor H for Complement Immune Evasion.劫持因子 H 以逃避补体免疫
Front Immunol. 2021 Feb 25;12:602277. doi: 10.3389/fimmu.2021.602277. eCollection 2021.
9
Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci.补体因子H样蛋白1的募集促进A组链球菌的细胞内侵袭。
Infect Immun. 2003 Dec;71(12):7119-28. doi: 10.1128/IAI.71.12.7119-7128.2003.
10
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.肺癌细胞中补体因子H的表达:对补体替代途径激活的影响
Cancer Res. 2004 Sep 1;64(17):6310-8. doi: 10.1158/0008-5472.CAN-03-2328.

引用本文的文献

1
Common Haplotypes within the Chromosome 1q31.3 Region Determine Systemic Concentrations of the Entire Complement Factor H Protein Family.1号染色体1q31.3区域内的常见单倍型决定整个补体因子H蛋白家族的系统浓度。
J Innate Immun. 2025;17(1):244-261. doi: 10.1159/000545342. Epub 2025 Mar 26.
2
Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways.三融合蛋白(TriFu):一种对所有三种补体激活途径均有效的、靶向性的、类似酶的抑制剂。
J Biol Chem. 2024 Apr;300(4):105784. doi: 10.1016/j.jbc.2024.105784. Epub 2024 Feb 23.
3
AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model.
AAV 基因增强截断补体因子 H 可在小鼠模型中差异拯救眼部补体失调。
Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):25. doi: 10.1167/iovs.64.10.25.
4
Bruch's Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration.布鲁赫膜:年龄相关性黄斑变性基于补体疗法的关键考量因素
J Clin Med. 2023 Apr 14;12(8):2870. doi: 10.3390/jcm12082870.
5
Modeling C3 glomerulopathies: C3 convertase regulation on an extracellular matrix surface.建模 C3 肾小球疾病:细胞外基质表面上的 C3 转化酶调节。
Front Immunol. 2023 Jan 18;13:1073802. doi: 10.3389/fimmu.2022.1073802. eCollection 2022.
6
The Factor H protein family: The switchers of the complement alternative pathway.补体旁路途径的开关:因子 H 蛋白家族。
Immunol Rev. 2023 Jan;313(1):25-45. doi: 10.1111/imr.13166. Epub 2022 Nov 16.
7
Exploratory Investigation of the Plasma Proteome Associated with the Endotheliopathy of Trauma.创伤性内皮病相关血浆蛋白质组学的探索性研究。
Int J Mol Sci. 2022 Jun 1;23(11):6213. doi: 10.3390/ijms23116213.
8
Systems Biology Modeling of the Complement System Under Immune Susceptible Pathogens.免疫易感病原体下补体系统的系统生物学建模
Front Phys. 2021 Apr 29;9. doi: 10.3389/fphy.2021.603704.
9
Complement Factor H Family Proteins Modulate Monocyte and Neutrophil Granulocyte Functions.补体因子 H 家族蛋白调节单核细胞和中性粒细胞的功能。
Front Immunol. 2021 Oct 4;12:660852. doi: 10.3389/fimmu.2021.660852. eCollection 2021.
10
Two human antibodies to a meningococcal serogroup B vaccine antigen enhance binding of complement Factor H by stabilizing the Factor H binding site.两种针对脑膜炎奈瑟菌 B 群疫苗抗原的人源抗体通过稳定因子 H 结合位点增强补体因子 H 的结合。
PLoS Pathog. 2021 Jun 14;17(6):e1009655. doi: 10.1371/journal.ppat.1009655. eCollection 2021 Jun.